TG Therapeutics (TGTX) P/E ratio

P/E ratio today
93.6×

TG Therapeutics (TGTX) trades at 93.6× its earnings per share over the last twelve months. At the end of fiscal 2025 (December 31, 2025) its P/E ratio was 10.8×. That is 94.6% lower than the 200.7× of fiscal 2024. Figures as of 18 Nov 2026, 11:31 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/E ratio today
93.6×
P/E ratio, fiscal 2025
10.8×
Change on fiscal 2024
−94.6%
Highest on record
200.7×fiscal 2024
Lowest on record
10.8×fiscal 2025
Fiscal years on record
32023–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

TG Therapeutics P/E ratio, in more detail

Today's figure is 769.7% above the fiscal 2025 year-end.

Across the 3 fiscal year-ends on record (2023–2025), the highest was 200.7× in fiscal 2024 and the lowest 10.8× in fiscal 2025. Today's P/E ratio is higher than at 33% of the 3 fiscal year-ends on record; their median is 189.8×.

History · 3 fiscal years

P/E ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

TG Therapeutics P/E ratio, year by year

TG Therapeutics (TGTX) P/E ratio by fiscal year
Fiscal yearP/E ratioChangeYear endedShare price at year-endDiluted EPS
Today93.6×—$62.71—
202510.8× 94.6% down$29.81$2.77
2024200.7× 5.7% up$30.10$0.15
2023189.8×—$17.08$0.09
2022——$11.83-$1.46
2021——$19.00-$2.63
2020——$52.02-$2.42
2019——$11.10—
2018——$4.10—
2017——$8.20—
2016——$4.65—
2015——$11.93—
2014——$15.84—
2013——$3.90—
2012——$3.64—
2011——$1.13—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

How to read it

It is the number of years of current profit the price pays for — a high figure means investors expect growth, and it is best judged against the company's own history.

P/E ratio at health care companies of similar size

P/E ratio of TG Therapeutics and comparable companies
CompanyP/E ratio
Henry Schein HSIC22.7×
Oscar Health OSCR13.3×
TG Therapeutics TGTX93.6×

Price over the last twelve months' earnings per share, as the market data feed reports it.

More on TGTX

TG Therapeutics, figure by figure

TG Therapeutics (TGTX) overview: price, valuation and scorecardAll health care companies by market value

TG Therapeutics P/E ratio: questions and answers

What is TG Therapeutics's P/E ratio?

TG Therapeutics (TGTX) trades at 93.6× its earnings per share over the last twelve months. At the end of fiscal 2025 (December 31, 2025) its P/E ratio was 10.8×. That is 94.6% lower than the 200.7× of fiscal 2024.

Is TG Therapeutics's P/E ratio high or low compared with its own history?

Today's P/E ratio is higher than at 33% of the 3 fiscal year-ends on record; their median is 189.8×.

What are the highest and lowest P/E ratio figures on record for TG Therapeutics?

Across the 3 fiscal year-ends on record (2023–2025), the highest was 200.7× in fiscal 2024 and the lowest 10.8× in fiscal 2025.

How is TG Therapeutics's P/E ratio calculated?

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E. For TG Therapeutics it is on record here for 3 fiscal years, 2023 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “TG Therapeutics (TGTX) P/E ratio”, data as of 18 November 2026. https://funkfolio.com/stock/TGTX/pe-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.